Medicare Reimbursements and Shortages of Sterile Injectable Pharmaceuticals

Ali Yurukoglu

NBER Working Paper No. 17987
Issued in April 2012
NBER Program(s):   HC   HE   IO

This paper investigates the rise in shortages of sterile injectable pharmaceutical drugs in the US. I examine a policy change in 2005 that differentially reduced Medicare Part B payments for pharmaceuticals. Drugs whose payments dropped more due to the policy change have had greater increases in shortages. I interpret these results using a model of entry and capacity choice with supply uncertainty. I conclude that Medicare's generous payments before the policy change provided manufacturers with incentives to invest in capacity or induced entry. The effect on total welfare of lowering payments is theoretically ambiguous.

The NBER Bulletin on Aging and Health provides summaries of publications like this.  You can sign up to receive the NBER Bulletin on Aging and Health by email.

You may purchase this paper on-line in .pdf format from ($5) for electronic delivery.

Information about Free Papers

You should expect a free download if you are a subscriber, a corporate associate of the NBER, a journalist, an employee of the U.S. federal government with a ".GOV" domain name, or a resident of nearly any developing country or transition economy.

If you usually get free papers at work/university but do not at home, you can either connect to your work VPN or proxy (if any) or elect to have a link to the paper emailed to your work email address below. The email address must be connected to a subscribing college, university, or other subscribing institution. Gmail and other free email addresses will not have access.


This paper was revised on December 19, 2012

Machine-readable bibliographic record - MARC, RIS, BibTeX

Document Object Identifier (DOI): 10.3386/w17987

Users who downloaded this paper also downloaded these:
Dee w17990 School Turnarounds: Evidence from the 2009 Stimulus
Blinder and Krueger w15287 Alternative Measures of Offshorability: A Survey Approach
Danzon and Keuffel Regulation of the Pharmaceutical-Biotechnology Industry
Comin, Easterly, and gong w12657 Was the Wealth of Nations Determined in 1000 B.C.?
Stowasser, Heiss, McFadden, and Winter w17273 "Healthy, Wealthy and Wise?" Revisited: An Analysis of the Causal Pathways from Socio-economic Status to Health
NBER Videos

National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email:

Contact Us